Literature DB >> 25074920

p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.

Serif Senturk1, Zhan Yao1, Matthew Camiolo1, Brendon Stiles2, Trushar Rathod3, Alice M Walsh4, Alice Nemajerova5, Matthew J Lazzara4, Nasser K Altorki2, Adrian Krainer1, Ute M Moll5, Scott W Lowe3, Luca Cartegni3, Raffaella Sordella6.   

Abstract

Although much is known about the underlying mechanisms of p53 activity and regulation, the factors that influence the diversity and duration of p53 responses are not well understood. Here we describe a unique mode of p53 regulation involving alternative splicing of the TP53 gene. We found that the use of an alternative 3' splice site in intron 6 generates a unique p53 isoform, dubbed p53Ψ. At the molecular level, p53Ψ is unable to bind to DNA and does not transactivate canonical p53 target genes. However, like certain p53 gain-of-function mutants, p53Ψ attenuates the expression of E-cadherin, induces expression of markers of the epithelial-mesenchymal transition, and enhances the motility and invasive capacity of cells through a unique mechanism involving the regulation of cyclophilin D activity, a component of the mitochondrial inner pore permeability. Hence, we propose that p53Ψ encodes a separation-of-function isoform that, although lacking canonical p53 tumor suppressor/transcriptional activities, is able to induce a prometastatic program in a transcriptionally independent manner.

Entities:  

Keywords:  cancer; reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25074920      PMCID: PMC4136628          DOI: 10.1073/pnas.1321640111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Serial analysis of gene expression in normal p53 null mammary epithelium.

Authors:  C Marcelo Aldaz; Yuhui Hu; Rachael Daniel; Sally Gaddis; Frances Kittrell; Daniel Medina
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

2.  Tid1 isoforms are mitochondrial DnaJ-like chaperones with unique carboxyl termini that determine cytosolic fate.

Authors:  Bin Lu; Nuria Garrido; Johannes N Spelbrink; Carolyn K Suzuki
Journal:  J Biol Chem       Date:  2006-03-10       Impact factor: 5.157

3.  p53 suppresses the self-renewal of adult neural stem cells.

Authors:  Konstantinos Meletis; Valtteri Wirta; Sanna-Maria Hede; Monica Nistér; Joakim Lundeberg; Jonas Frisén
Journal:  Development       Date:  2006-01       Impact factor: 6.868

4.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells.

Authors:  Liqing Jin; Kristin J Hope; Qiongli Zhai; Florence Smadja-Joffe; John E Dick
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

5.  Aristolochic acid-associated urothelial cancer in Taiwan.

Authors:  Chung-Hsin Chen; Kathleen G Dickman; Masaaki Moriya; Jiri Zavadil; Viktoriya S Sidorenko; Karen L Edwards; Dmitri V Gnatenko; Lin Wu; Robert J Turesky; Xue-Ru Wu; Yeong-Shiau Pu; Arthur P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 6.  Epithelial-mesenchymal transition: implications in cancer progression and metastasis.

Authors:  L R Gomes; L F Terra; M C Sogayar; L Labriola
Journal:  Curr Pharm Biotechnol       Date:  2011-11       Impact factor: 2.837

Review 7.  Protein p53--structure, function, and possible therapeutic implications.

Authors:  Tanja Batinac; Franjo Gruber; Jasna Lipozencić; Gordana Zamolo-Koncar; Adalbert Stasić; Ines Brajac
Journal:  Acta Dermatovenerol Croat       Date:  2003-12       Impact factor: 1.256

Review 8.  New insights of epithelial-mesenchymal transition in cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

9.  p53 regulates maternal reproduction through LIF.

Authors:  Wenwei Hu; Zhaohui Feng; Angelika K Teresky; Arnold J Levine
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

Review 10.  Redox regulation of cell migration and adhesion.

Authors:  Thomas Ryan Hurd; Matthew DeGennaro; Ruth Lehmann
Journal:  Trends Cell Biol       Date:  2011-12-31       Impact factor: 20.808

View more
  37 in total

1.  The Evolution of TP53 Mutations: From Loss-of-Function to Separation-of-Function Mutants.

Authors:  Madison Miller; Nitin Shirole; Ruxiao Tian; Debjani Pal; Raffaella Sordella
Journal:  J Cancer Biol Res       Date:  2016-12-23

2.  Discovery of a p53 variant that controls metastasis.

Authors:  Chiara Gorrini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

Review 3.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD-L1 Expression.

Authors:  Xiaobo Yang; Junping Shi; Xiaoqian Chen; Yan Jiang; Haitao Zhao
Journal:  Oncologist       Date:  2020-02-26

5.  Δ113p53/Δ133p53 converts P53 from a repressor to a promoter of DNA double-stand break repair.

Authors:  Lu Gong; Jun Chen
Journal:  Mol Cell Oncol       Date:  2015-05-27

Review 6.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

7.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

8.  The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2.

Authors:  I Roth; H Campbell; C Rubio; C Vennin; M Wilson; A Wiles; G Williams; A Woolley; P Timpson; M V Berridge; N Fleming; M Baird; A W Braithwaite
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

Review 9.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

Review 10.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.